Andrew Thompson

Andrew Thompson is Director of Discovery & Technology at Inoviv, and Chief Scientific Officer at Arromed Ltd. Andrew has a strong background in developing new technologies and products in the field of proteomics and diagnostics. Andrew has experience in business plan development, fundraising, and collaboration with industry partners. Andrew holds a PhD in Biological Mass Spectrometry from the University of Cambridge.